Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, reflecting a site software version update.
    Difference
    0.1%
    Check dated 2026-10-18T05:40:41.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T08:10:44.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The history shows a minor UI text change in the contact information label (capitalization) and a revision tag update from v3.6.6 to v3.7.0.
    Difference
    0.2%
    Check dated 2026-09-20T03:48:35.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new site revision entry, v3.6.6, is added to the study record history, replacing the prior v3.6.5 and indicating a recent system update.
    Difference
    0.1%
    Check dated 2026-08-29T23:43:56.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision bumped from v3.6.4 to v3.6.5 in the page history, signaling an internal software update to the record history interface.
    Difference
    0.1%
    Check dated 2026-08-08T19:51:50.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The Record History now shows the platform revision updated to v3.6.4, replacing v3.6.3. This is a system update to the ClinicalTrials.gov interface and does not change the study data or its presentation beyond the version label.
    Difference
    0.1%
    Check dated 2026-07-25T11:48:56.000Z thumbnail image

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.